Update on the Treatment of Hematologic Malignancies in HIV-Infected Patients: Bone Marrow Transplant vs. CAR T-Cell Therapy
Medical interventions in the management of HIV patients have improved treatment outcomes for this patient population. While treatment outcomes continue to improve, malignancies associated with HIV appear to be increasing. During this course, Dr. Marco Ruiz will describe the etiology of hematologic malignancies in HIV patients and analyze refined evidence-based treatment options for HIV-associated hematologic malignancies.
Hospitalists, Physician Assistants, Nurses, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers.
- Describe the etiology of hematologic malignancies in HIV-infected patients.
- Analyze refined treatment options for HIV-infected patients – revisiting bone marrow transplant and CAR T-cell therapy – to determine the best course of treatment for these patients.
- Recognize the importance of utilizing the appropriate sequence in the treatment of HIV-associated hematologic malignancies.
Marco Ruiz, M.D., MPH, FACP, FIDSA, FRSPH
Chief of HIV Oncology
Associate Director, Bone Marrow Transplant Program
Program Director, Malignant Hematology/Bone Marrow Transplant APP Fellowship Program
Miami Cancer Institute
Marco Ruiz, M.D., faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Tina C. Sanjar, M.D., MBA, conference director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.